These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24562640)

  • 1. Altered serotonin transporter availability in patients with multiple sclerosis.
    Hesse S; Moeller F; Petroff D; Lobsien D; Luthardt J; Regenthal R; Becker GA; Patt M; Thomae E; Seese A; Meyer PM; Bergh FT; Sabri O
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):827-35. PubMed ID: 24562640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.
    Frick A; Åhs F; Palmquist ÅM; Pissiota A; Wallenquist U; Fernandez M; Jonasson M; Appel L; Frans Ö; Lubberink M; Furmark T; von Knorring L; Fredrikson M
    Mol Psychiatry; 2016 Oct; 21(10):1400-7. PubMed ID: 26619809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.
    Schmidt E; Schinke C; Rullmann M; Luthardt J; Becker GA; Haars S; Stoppe M; Lobsien D; Hoffmann KT; Sabri O; Hesse S; Then Bergh F
    Sci Rep; 2020 Sep; 10(1):14651. PubMed ID: 32887904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Svarer C; Baaré W; Budtz-Joergensen E; Madsen K; Madsen J; Kessing LV; Knudsen GM
    Neuroimage; 2009 Jun; 46(2):360-6. PubMed ID: 19233297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
    Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
    Vanicek T; Kutzelnigg A; Philippe C; Sigurdardottir HL; James GM; Hahn A; Kranz GS; Höflich A; Kautzky A; Traub-Weidinger T; Hacker M; Wadsak W; Mitterhauser M; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2017 Feb; 38(2):792-802. PubMed ID: 27770470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB.
    Frankle WG; Narendran R; Huang Y; Hwang DR; Lombardo I; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2005 Jun; 57(12):1510-6. PubMed ID: 15953487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
    Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
    Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.
    Politis M; Wu K; Loane C; Turkheimer FE; Molloy S; Brooks DJ; Piccini P
    Neurology; 2010 Nov; 75(21):1920-7. PubMed ID: 21098407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
    Frankle WG; Robertson B; Maier G; Paris J; Asmonga D; May M; Himes ML; Mason NS; Mathis CA; Narendran R
    Synapse; 2018 Mar; 72(3):. PubMed ID: 29216407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: a [11C]DASB PET study.
    Kupers R; Frokjaer VG; Erritzoe D; Naert A; Budtz-Joergensen E; Nielsen FA; Kehlet H; Knudsen GM
    Neuroimage; 2011 Jan; 54(2):1336-43. PubMed ID: 20851771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.